Claritev (CTEV) Net Margin (2019 - 2026)
Claritev's quarterly Net Margin came in at 30.06% in Q1 2026, up 77.0% year-on-year from 16.99% in Q1 2025, and up 8.02% quarter-over-quarter from 32.69% in Q4 2025.
Claritev has reported Net Margin for 8 years, with the latest figure at 30.06% in Q1 2026.
- For the quarter ending Q1 2026, Net Margin rose 77.0% year-over-year to 30.06%; the trailing twelve-month figure through Mar 2026 stood at 29.28% (up 9768.0% YoY), and the FY2025 full-year result was 29.45%, up 14740.0% from the prior year.
- Net Margin for Q1 2026 stood at 30.06%, up from 32.69% in the prior quarter.
- The five-year high for Net Margin was 14.76% in Q1 2022, with the low at 269.65% in Q4 2022.
- Average Net Margin over 5 years is 66.74%, with a median of 28.36% recorded in 2025.
- Year-over-year, Net Margin sank 27801 bps in 2022 and soared 25679 bps in 2023.
- Tracing CTEV's Net Margin over 5 years: stood at 269.65% in 2022, then surged by 95 bps to 12.86% in 2023, then plunged by 362 bps to 59.42% in 2024, then jumped by 45 bps to 32.69% in 2025, then gained by 8 bps to 30.06% in 2026.
- The last three Net Margin figures came in at 30.06% (Q1 2026), 32.69% (Q4 2025), and 28.36% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | 29.21% |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 2.06% |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | 19.57% |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | 18.66% |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 13.15% |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 13.80% |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | -8.93% |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | 0.61% |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 3.68% |
| 10 | Claritev | 456.62 Mn | 428.62 Mn | 175.60 Mn | -30.06% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -30.06% |
| Dec 31, 2025 | -32.69% |
| Sep 30, 2025 | -28.36% |
| Jun 30, 2025 | -25.93% |
| Mar 31, 2025 | -30.83% |
| Dec 31, 2024 | -59.42% |
| Sep 30, 2024 | -169.83% |
| Jun 30, 2024 | -247.02% |
| Mar 31, 2024 | -230.14% |
| Dec 31, 2023 | -12.86% |
| Sep 30, 2023 | -9.94% |
| Jun 30, 2023 | -15.28% |
| Mar 31, 2023 | 0.09% |
| Dec 31, 2022 | -269.65% |
| Sep 30, 2022 | 7.88% |
| Jun 30, 2022 | 4.66% |
| Mar 31, 2022 | 14.76% |
| Dec 31, 2021 | 8.36% |
| Sep 30, 2021 | 27.13% |
| Jun 30, 2021 | -16.99% |
| Mar 31, 2021 | 18.00% |
| Dec 31, 2020 | 175.98% |
| Sep 30, 2020 | -129.03% |
| Jun 30, 2020 | -27.19% |
| Mar 31, 2020 | -1.03% |
| Dec 31, 2019 | 41.67% |